Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: Gerald F Bunch who wrote (29959)	7/18/1998 4:48:00 PM
From: Knighty Tin	Read Replies (2) \| Respond to of 132070

GB, I actually already know a bit about this tiny San Diego biotech firm. My feeling is that they are a venture capital company with as much risk as potential. So, if you are talking about wild speculation, Tegra is a decent bet. If you are talking about a serious investment with money that cannot afford to be lost, I would shy away. On the positive side, they have selling products, but, IMHO, the sale of peptides is much too small to support any type of research program. They do not have great partnerships with major firms, so the only way to raise money is to sell stock. And they have nothing at even a phase II level yet. So, I would definitely consider the stock in a speculative play that included 5-12 other biotech names. But for a one-shot play, it is simply too small and too uncertain at this time. They are serious folks and not scamming anyone, and the science looks o.k., though not as focused as I would prefer. Still, it is a start up level venture, good for a gamble but not for a huge investment. Hope this made sense. MB